Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|September 27, 2025
Update on Structure and Function of SH2 Domains: Mechanisms and Emerging Targeting StrategiesMoses M Kasembeli, Jorge Rodas, David J Tweardy
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
SH2 domain binding to phosphopeptide ligands: potential for drug targetingMoses M Kasembeli, Xuejun Xu, David J Tweardy
International Journal of Molecular Sciences|August 8, 2018
Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for TreatmentMoses M Kasembeli, Uddalak Bharadwaj, Prema Robinson, et al.
JAK-STAT|September 29, 2015
Contribution of chaperones to STAT pathway signalingClaire E Bocchini, Moses M Kasembeli, Soung-Hun Roh, et al.
Plos One|March 11, 2009
Chemical probes that competitively and selectively inhibit Stat3 activationXuejun Xu, Moses M Kasembeli, Xueqing Jiang, et al.
Biophysical Journal|June 9, 2016
Chaperonin TRiC/CCT Recognizes Fusion Oncoprotein AML1-ETO through Subunit-Specific InteractionsSoung-Hun Roh, Moses M Kasembeli, Jesús G Galaz-Montoya, et al.
Blood|October 14, 2022
Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimersMoses M Kasembeli, Efiyenia Kaparos, Uddalak Bharadwaj, et al.
Lung Cancer (Amsterdam, Netherlands)|September 28, 2015
Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancerKatherine M Lewis, Uddalak Bharadwaj, T Kris Eckols, et al.
Pageof 2